Pfizer Q2 net profit falls 14% to Rs 95.8 crore
New Delhi: Drug firm Pfizer has recently reported a 13.81 per cent dip in standalone net profit to Rs 95.8 crore for the quarter ended September 2018.
The company had posted a net profit of Rs 111.15 crore for the corresponding period of the previous fiscal.
Revenue from operations of the company stood at Rs 519.74 crore in the quarter under review. It was Rs 571.11 crore in the September quarter a year ago, Pfizer said in a filing to BSE.
Read Also: Pfizer loses blockbuster Epilepsy drug patent fight in UK Supreme Court
The company had posted a net profit of Rs 111.15 crore for the corresponding period of the previous fiscal.
Revenue from operations of the company stood at Rs 519.74 crore in the quarter under review. It was Rs 571.11 crore in the September quarter a year ago, Pfizer said in a filing to BSE.
Read Also: Pfizer loses blockbuster Epilepsy drug patent fight in UK Supreme Court
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd